Physician
North Clinic, PA
North Clinic, PA was paid $4.53M by Medicaid between Jan 2018 and Dec 2024, across 120 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoNORTH CLINIC, PA
BROOKLYN PARK, MN 55445
BROOKLYN PARK, MN 55445
33aNPI1114962206assigned 06/20/2006
33bProvider typeRheumatology Physician
28Total paid$4.53M
24GClaims163,303
24DCodes billed120
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rheumatology Physician providers in Minnesota
Rank by total paid#1 of 6
Median peer was paid$14K
This provider vs. median333×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,133 | $196K | |
| 2019 | 30,176 | $773K | |
| 2020 | 26,514 | $716K | |
| 2021 | 30,769 | $985K | |
| 2022 | 19,710 | $805K | |
| 2023 | 13,612 | $589K | |
| 2024incomplete | 11,389 | $468K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 24,309 | 21,760 | $1.59M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 27,618 | 24,617 | $1.33M |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 3.5% | 623 | 294 | $157K |
| 20611 | 3.4% | 1,814 | 1,132 | $152K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.5% | 1,456 | 1,325 | $115K |
| 36415 | Collection of venous blood by venipuncture | 1.7% | 23,536 | 21,473 | $78K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 1,015 | 994 | $70K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 961 | 897 | $69K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1.4% | 27 | 24 | $63K |
| 96127 | 1.3% | 17,414 | 15,662 | $59K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.3% | 5,219 | 5,042 | $59K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 730 | 726 | $51K |
108 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 365 | $44K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,244 | $41K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 720 | $40K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 441 | $35K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 999 | $30K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 999 | $30K |
| 80061 | Lipid panel | <1% | 2,654 | $30K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,930 | $29K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 196 | $23K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 633 | $22K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,829 | $22K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,159 | $18K |
| 85027 | <1% | 3,059 | $17K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 528 | $16K |
| 90686 | <1% | 1,701 | $16K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 322 | $16K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 538 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 279 | $15K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 194 | $14K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 207 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,584 | $11K |
| 99490 | Ccm add 20min | <1% | 2,174 | $11K |
| 20610 | <1% | 198 | $10K | |
| 82565 | <1% | 1,886 | $9K | |
| 86780 | <1% | 611 | $9K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 399 | $9K |
| 84460 | <1% | 1,659 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,109 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 810 | $7K |
| 84450 | <1% | 1,428 | $7K | |
| 81001 | <1% | 2,344 | $7K | |
| 90670 | <1% | 719 | $6K | |
| 86140 | <1% | 1,325 | $6K | |
| 87210 | <1% | 1,276 | $6K | |
| 90715 | <1% | 334 | $6K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 169 | $6K |
| 84075 | <1% | 1,138 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 209 | $5K |
| 87428 | <1% | 93 | $5K | |
| 80076 | <1% | 690 | $5K | |
| 0004A | <1% | 128 | $5K | |
| 90688 | <1% | 870 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 40 | $4K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 56 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 194 | $4K |
| 0001A | <1% | 127 | $4K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,307 | $4K |
| 84703 | <1% | 552 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 198 | $4K |
| 87081 | <1% | 618 | $4K | |
| 0002A | <1% | 103 | $4K | |
| 87430 | <1% | 258 | $3K | |
| 85651 | <1% | 794 | $3K | |
| 11721 | <1% | 127 | $3K | |
| G0008 | Administration of influenza virus vaccine | <1% | 675 | $3K |
| 0054A | <1% | 69 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 160 | $3K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 480 | $3K |
| 85018 | <1% | 1,296 | $3K | |
| 93000 | <1% | 334 | $3K | |
| 0064A | <1% | 82 | $3K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 339 | $2K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 27 | $2K |
| 0071A | <1% | 55 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 93 | $2K |
| 99442 | <1% | 60 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 107 | $2K |
| 99188 | <1% | 136 | $2K | |
| 0072A | <1% | 38 | $2K | |
| 82728 | <1% | 97 | $1K | |
| 86703 | <1% | 192 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 12 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $956.97 |
| 0011A | <1% | 63 | $859.33 | |
| 0012A | <1% | 60 | $843.86 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 209 | $830.11 |
| 82947 | <1% | 229 | $825.98 | |
| 80306 | <1% | 40 | $801.40 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 189 | $739.49 |
| 90474 | <1% | 81 | $499.80 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 13 | $470.33 |
| 0124A | <1% | 12 | $422.70 | |
| 99173 | <1% | 239 | $374.60 | |
| 73565 | <1% | 14 | $353.33 | |
| 99000 | <1% | 14 | $350.00 | |
| 82570 | <1% | 71 | $344.26 | |
| 84466 | <1% | 26 | $317.96 | |
| 85610 | <1% | 277 | $299.68 | |
| 90677 | <1% | 12 | $292.08 | |
| 84439 | <1% | 39 | $268.38 | |
| 96415 | <1% | 15 | $261.17 | |
| 83540 | <1% | 38 | $245.74 | |
| 80053 | Comprehensive metabolic panel | <1% | 14 | $160.52 |
| 82950 | <1% | 25 | $139.35 | |
| 82043 | <1% | 26 | $117.16 | |
| 83735 | <1% | 12 | $92.94 | |
| 90656 | <1% | 19 | $88.54 | |
| 90710 | 0% | 26 | $0.00 | |
| X5622 | 0% | 146 | $0.00 | |
| 90633 | 0% | 34 | $0.00 | |
| 90653 | 0% | 12 | $0.00 | |
| 86592 | 0% | 107 | $0.00 | |
| 90647 | 0% | 272 | $0.00 | |
| 92551 | 0% | 12 | $0.00 | |
| 90723 | 0% | 270 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 63 | $0.00 |
| 90680 | 0% | 101 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOLSON, SCOTT (PRESIDENT)